Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $311.41 million. The enterprise value is -$264.30 million.
| Market Cap | 311.41M |
| Enterprise Value | -264.30M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 84.16 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Shares Outstanding | 84.16M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 9.46% |
| Owned by Institutions (%) | 67.50% |
| Float | 63.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.24, with a Debt / Equity ratio of 0.00.
| Current Ratio | 18.24 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.10% and return on invested capital (ROIC) is -29.44%.
| Return on Equity (ROE) | -23.10% |
| Return on Assets (ROA) | -22.00% |
| Return on Capital (ROIC) | -29.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.81M |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVIR has paid $1.02 million in taxes.
| Income Tax | 1.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.85% in the last 52 weeks. The beta is 0.16, so AVIR's price volatility has been lower than the market average.
| Beta (1Y) | 0.16 |
| 52-Week Price Change | +13.85% |
| 50-Day Moving Average | 4.02 |
| 200-Day Moving Average | 3.47 |
| Relative Strength Index (RSI) | 40.30 |
| Average Volume (30 Days) | 421,064 |
Short Selling Information
The latest short interest is 1.67 million, so 1.98% of the outstanding shares have been sold short.
| Short Interest | 1.67M |
| Short Previous Month | 1.70M |
| Short % of Shares Out | 1.98% |
| Short % of Float | 2.61% |
| Short Ratio (days to cover) | 3.77 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -164.16M |
| Pretax Income | -134.94M |
| Net Income | -135.96M |
| EBITDA | -134.52M |
| EBIT | -134.94M |
| Earnings Per Share (EPS) | -$1.63 |
Balance Sheet
The company has $578.11 million in cash and $2.40 million in debt, giving a net cash position of $575.70 million or $6.84 per share.
| Cash & Cash Equivalents | 578.11M |
| Total Debt | 2.40M |
| Net Cash | 575.70M |
| Net Cash Per Share | $6.84 |
| Equity / Book Value | 555.19M |
| Book Value Per Share | 6.60 |
| Working Capital | 558.08M |
Cash Flow
| Operating Cash Flow | -85.40M |
| Capital Expenditures | n/a |
| Free Cash Flow | -85.40M |
| FCF Per Share | -$1.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.17% |
| Earnings Yield | -43.66% |
| FCF Yield | -27.42% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |